# Soni Medicare (NSE: SML) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SML · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹30 Cr, it ranks 3380th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Other Industrial Metals & Mining.

Its return on equity was 19.4% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹6 Cr (−15.1% year on year) and net profit −₹0 Cr (−202.8%), on a standalone basis. Promoters held 69.79% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹30 Cr |
| ROE | 19.4% (FY25) |
| ROCE | 31.1% (FY25) |
| Debt to equity | 0.08 |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹6 Cr | −15.1% | −₹0 Cr | −202.8% | −₹0.45 |
| Q3 FY26 | ₹5 Cr | −28.7% | −₹1 Cr | — | −₹2.65 |
| Q2 FY26 | ₹6 Cr | −25.5% | −₹1 Cr | −295.7% | −₹2.16 |
| Q1 FY26 | ₹7 Cr | +2.8% | −₹0 Cr | — | −₹0.68 |
| Q4 FY25 | ₹7 Cr | +0.1% | ₹0 Cr | — | ₹0.55 |
| Q3 FY25 | ₹8 Cr | +39.8% | −₹0 Cr | — | −₹0.31 |
| Q2 FY25 | ₹8 Cr | +11.9% | ₹0 Cr | +1,466.7% | ₹1.09 |
| Q1 FY25 | ₹7 Cr | −6.1% | −₹1 Cr | −1,066.7% | −₹2.03 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹157 Cr | ₹16 Cr |
| FY24 | ₹115 Cr | ₹12 Cr |
| FY23 | ₹109 Cr | ₹11 Cr |
| FY22 | ₹67 Cr | ₹11 Cr |
| FY21 | ₹38 Cr | ₹8 Cr |
| FY20 | ₹6 Cr | ₹6 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 69.79%
- Non-institutions: 30.21%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Medi-Caps](https://app.pivotnow.in/stock/MEDICAPQ) | ₹25.50 | ₹32 Cr | — | — |
| [KK Shah Hospita](https://app.pivotnow.in/stock/KKSHL) | — | ₹30 Cr | — | — |
| [Panjon](https://app.pivotnow.in/stock/PANJON) | — | ₹30 Cr | — | — |
| [Chennai Meenaks](https://app.pivotnow.in/stock/CMMHOSP) | — | ₹29 Cr | — | — |
| [Tejnaksh](https://app.pivotnow.in/stock/TEJNAKSH) | — | ₹29 Cr | — | — |
| [SAMSRITA LABS](https://app.pivotnow.in/stock/SAMSRITA) | — | ₹28 Cr | — | — |

## Questions and answers

### What is the market cap of Soni Medicare?

Soni Medicare's market capitalisation is ₹30 Cr (₹30 Cr) at the 22 Oct 2026 close, ranking 3380th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Soni Medicare?

Return on equity was 19.4% in FY25 and return on capital employed was 31.1% in FY25 (standalone figures).

### Is Soni Medicare a debt-free company?

No. Soni Medicare's debt-to-equity ratio was 0.08 in FY25, with total debt of ₹0 Cr.

### What were Soni Medicare's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Soni Medicare reported revenue of ₹6 Cr, −15.1% year on year, and net profit of −₹0 Cr, −202.8% year on year.

### What is the shareholding pattern of Soni Medicare?

As of 30 Jun 2026: promoters 69.79%, non-institutions 30.21%.

### Who are Soni Medicare's competitors?

The listed Pharma & Healthcare companies closest to Soni Medicare by market cap are Medi-Caps, KK Shah Hospita, Panjon, Chennai Meenaks, Tejnaksh and SAMSRITA LABS.

### Is Soni Medicare a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Soni Medicare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SML against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.